Abstract
We reported previously that adenocarcinoma-reactive human monoclonal antibody AE6F4, which had been generated by in vitro immunization method, recognizes both 14-3-3protein and cytokeratin 8 (CK8). In this study, to analyze the cross-reactivity of AE6F4 antibody, epitopes of AE6F4 antibody on 14-3-3 proteins and CK8 were studied by using synthetic linear peptide scanning technology. To determine the locations of B cell epitope, 48 and 95 of decapeptides covering the entire 14-3-3 proteins and CK8, respectively,were synthesized and binding to AE6F4 antibody was examined by ELISA. The AE6F4 antibody was strongly reactive to peptides containing amino acid sequences TLWTSDTQGD in 14-3-3 proteins and INFLRQLYEE in CK8. These results indicate that AE6F4 antibody can recognize the different peptide sequences in 14-3-3 proteins and CK8.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ichikawa A, Tachibana H, Kawamoto S, Kamei M, Honjoh T, Hashizume S & Shirahata S (1997) Cytokeratin 8 and 19 as antigens recognized by adenocarcinoma-reactive human monoclonal antibody AE6F4. Hum Antibod 8: 195–202.
Kawahara H, Shirahata S, Tachibana H & Murakami H (1992) In vitro immunization of human peripheral blood lymphocytes with human cancer cell line A549. Hum Antibodies Hybridomas 3: 8–13.
Kawamoto S, Shoji M Setoguchi Y, Kato M, Hashizume S, Ichikawa A, Osada K, Katakura Y, Tachibana H & Murakami H (1995) Molecular cloning of the 31 kDa cytosolic phospholipase A2, as an antigen recognized by the lung cancer specific human monoclonal antibody, AE6F4. Cytotechnology 17: 103–108.
Nakanishi K, Hashizume S, Kato M, Honjoh T, Setoguchi Y & Yasumoto K (1997) Elevated expression levels of the 14-3-3 family of proteins in lung cancer tissues. Hum Anitibod 8: 189–194.
Shoji M, Kawamoto S, Sato S, Kamei M, Kato M, Hashizume S, Seki K, Yasumoto K, Nagashima A, Nakanishi H, Suzuki T, Imai T, Nomoto K & Murakami H (1994a) Specific reactivity of human monoclonal antibody AE6F4 against cancer cells in tissues and sputa from lung cancer patients. Hum Antibodies Hybridomas 5: 116–122.
Shoji M, Kawamoto S, Setoguchi Y, Mochizuki K, Honjoh T, Kato M, Hashizume S, Hanagiri T, Yoshimasu T, Nakanishi K, Yasumoto K, Nagashima A, Nakanishi H, Suzuki T, Imai T, Nomoto K & Murakami H (1994b) The 14-3-3 protein as the antigen for lung cancer-associated human monoclonal antibody AE6F4. Hum Antibodies Hybridomas 5: 123–130.
Stieber P, Bodenmuller H, Banauch D, Hasholzner U, Dessauer A, Ofenloch-Hahnle B, Jaworek D & Fateh-Moghadam A (1993) Cytokeratin 19 fragments: A new marker for non-small-cell lung cancer. Clin Biochem 26: 301–304.
Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA & Reed SG (2000) Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 110: 374–381.
Woodward MP, Young WWJ & Bloodgood RA (1985) Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods 78: 143–153.
Xu XC, Lee JS, Lippman SM, Ro JY, Hong WK & Lotan R (1995) Increased expression of cytokeratins CK8 and CK19 is associated with head and neck carcinogenesis. Cancer Epidemiol Biomarkers Prev 4: 871–876.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ichikawa, A., Shim, SY., Katakura, Y. et al. Molecular analysis of cross-reactive human monoclonal antibody AE6F4 generated by in vitro immunization: Epitope mapping of AE6F4 antibody on 14-3-3 family proteins and cytokeratin 8. Cytotechnology 36, 101–107 (2001). https://doi.org/10.1023/A:1014060113186
Issue Date:
DOI: https://doi.org/10.1023/A:1014060113186